Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNapoli, Italy was replaced with Naples, Italy and the Naples site was added to the study locations. The page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This appears to be an internal version update not affecting study content or user-facing features.SummaryDifference0.0%

- Check49 days agoChange DetectedThe revision label was updated from v3.4.1 to v3.4.2. No core content or functionality of the study page appears to be affected.SummaryDifference0.0%

- Check57 days agoChange DetectedMinor site version update: Revision tag changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange DetectedA new site revision label v3.3.4 was added, replacing v3.3.3; no changes to the study details or navigation are evident.SummaryDifference0.0%

- Check100 days agoChange DetectedLocations for participating sites across multiple US states (Alabama, California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Tennessee, Wisconsin) and Canadian provinces (Ontario, Quebec) have been added/updated. The page now presents a consolidated list of study locations, reflecting a restructuring of how sites are listed.SummaryDifference0.8%

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.